US regulatory status: approved. Molecular target: Fatty-acid amide hydrolase 1.
- Target
- Fatty-acid amide hydrolase 1
- Mechanism
- Cyclooxygenase inhibitor
biotech · Relapsed/Refractory Multiple Myeloma · Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech
Nanjing Legend Biotech Co.
Nanjing Legend Biotech drug portfolio — 17 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
2101 Cottontail Lane, Somerset, New Jersey 08873, US HQ
2,457 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 2101 Cottontail Lane, Somerset, New Jersey 08873, US
- Employees
- 2,457
- Programs
- 36
- Drugs
- 17
- Patents
- 26
Nanjing Legend Biotech pipeline
Portfolio lens on 17 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Nanjing Legend Biotech drug portfolio — 17 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
enoxaparin sodium
Blood and blood forming organs (B01)US regulatory status: approved. Molecular target: Antithrombin-III.
- Target
- Antithrombin-III
- Mechanism
- Antithrombin-III activator
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.
-
Development asset linked to Nanjing Legend Biotech in public FDA and regional records.